Related Experiment Videos
Combination therapy in early rheumatoid arthritis
1René Descartes University, Cochin Hospital, Paris, France.
Clinical and Experimental Rheumatology
|February 19, 2004
Summary
Early rheumatoid arthritis (RA) management aims to prevent joint damage and achieve remission. Combination disease-modifying therapy is increasingly recommended for early RA patients to attain persistent remission.
Area of Science:
- Rheumatology
- Immunology
- Clinical Medicine
Background:
- Rheumatoid arthritis (RA) course is established early, necessitating prompt intervention.
- Key goals in early RA include preventing radiologic joint degradation and achieving clinical and biological remission.
Purpose of the Study:
- To review randomized clinical trial data on initial combination disease-modifying therapy strategies in early RA.
- To assess the impact and potential future role of combination therapy in managing early rheumatoid arthritis.
Main Methods:
- Systematic review of randomized clinical trials.
- Analysis of treatment strategies for early rheumatoid arthritis (RA).
Main Results:
- Combination disease-modifying therapy is a viable strategy for early RA.
- Data suggests a growing role for combination therapy in achieving remission in early RA.
Conclusions:
- Combination therapy is likely to become more prevalent for early RA patients.
- The ultimate goal of persistent remission supports the use of combination therapy even in very early RA cases.